Press Releases Items Per Page 102550 Year None20212020201920182017201620152014 07-26-2021 Daré Bioscience to Present at the 2021 Controlled Release Society Virtual Annual Meeting to be held July 25-29, 2021 07-12-2021 Daré Announces Collaborative Research Agreement (CRADA) for the Pivotal Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Contraceptive 06-28-2021 Daré Bioscience Announces Positive Phase 1 Results for DARE-HRT1 06-04-2021 Daré Bioscience to Present at 2021 BIO Digital 05-13-2021 Daré Bioscience Reports First Quarter 2021 Financial Results and Provides a Company Update 05-06-2021 Daré Bioscience to Host First Quarter 2021 Financial Results and Company Update Conference Call and Webcast on May 13, 2021 04-27-2021 Daré Bioscience Announces Ovaprene®, a Novel Investigational Hormone-Free Contraceptive, Poster Presentation at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists 04-26-2021 Daré Bioscience Announces the Presentation of DARE-BVFREE Phase 3 Clinical Trial Results at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists 04-19-2021 Daré Bioscience Appoints Dr. Sophia N. Ononye-Onyia to its Board of Directors 03-30-2021 Daré Bioscience Reports Full Year 2020 Financial Results and Provides a Company Update Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 20
07-26-2021 Daré Bioscience to Present at the 2021 Controlled Release Society Virtual Annual Meeting to be held July 25-29, 2021
07-12-2021 Daré Announces Collaborative Research Agreement (CRADA) for the Pivotal Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Contraceptive
05-13-2021 Daré Bioscience Reports First Quarter 2021 Financial Results and Provides a Company Update
05-06-2021 Daré Bioscience to Host First Quarter 2021 Financial Results and Company Update Conference Call and Webcast on May 13, 2021
04-27-2021 Daré Bioscience Announces Ovaprene®, a Novel Investigational Hormone-Free Contraceptive, Poster Presentation at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists
04-26-2021 Daré Bioscience Announces the Presentation of DARE-BVFREE Phase 3 Clinical Trial Results at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists
